July 12, 2023 7:44am
Troubles sector’s share pricing increasing risk trepidation
My interpretation of the morning’s numbers is written to be informative; it’s built on what happened or will happen behind the headline today, not yesterday with a bit for tomorrow.
Subscription is coming, it’s not conscription but, an offer to join our collective of like-minded investors! Never leave an investor uninformed!
8:00 a.m. edition
Remember that overnight and pre-open actions in futures don't necessarily translate into actual trading in the coming day’s session. My interpretation of the morning’s numbers is written to be informative; it’s built on what will happen behind the headlines today, not tomorrow or yesterday
Dow futures are UP +0.16% or (+56 points), S&P futures are UP +0.26% or (+11 points) and NASDAQ futures are UP +0.29% or (+44 points) early in the pre-open – so far
U.S. stock futures were slightly higher Wednesday morning,
European markets were higher,
Asia-Pacific markets were mixed
Henry’omics:
We need to more than consider the economic environment - rising rates and inflation to comprehend the micro re “our” universe of cell and gene therapy companies …
Indexes rose Tuesday, as the Dow closed UP +317.02 points (+0.93%), the S&P closed UP +29.73 points (+0.67%) while the Nasdaq closed UP +75.22 points (+0.55%).
Economic Data Docket: June consumer price index reading; economists anticipate the closely followed inflation indicator will rise 0.3% from May and 3.1% on an annualized basis. Excluding volatile food and energy prices, the so-called core CPI is forecasted to increase 0.3% on the month and 5% on the year.
Tuesday, July 11, 2023, RegMed Investors’ (RMi) closing bell: “caution seems to be the sector’s word for the session. Many investors and traders are split on forecast ahead of inflation data.” … https://www.regmedinvestors.com/articles/13039
Ebb and flow:
Q3: July - 1 holiday, 4 positive and 2 negative close
Q2/23 -
· June -1 Holiday, 9 negative and 11 positive closes
· May – 10 negative and 12 positive closes
· April ended - 1 holiday, 8 positive close and 11 negative closes
Q1/23 –-
· March – ended with 10 positive and 13 negative closes
· February – 1 holiday, 2 vacation, 7 negative and 8 positive closes
· January – 2 holidays, 11 positive and 9 negative closes
Companies in my headlights – It’s your decision; I provide ideas and context: INDICATIONS
I am passing on a forecast for a session as economic/inflation reports usually throw “shade” on sector share pricing
The BOTTOM LINE:
I follow the dictum, quoting Churchill that “short words are best, and the old words when short are best of all, as I try to keep it simple and short!
The Nasdaq is still 5.7% above its 50-day line. That's not extended, but it wouldn't take much to get there. On the flip side, a 21-day line test could be constructive. <IBD>
Q3/23 – July: so far
· Tuesday closed positive with 18 incliners, 14 decliners and 3 flats
· Monday closed positive with 25 incliners, 7 decliners and 3 flats
· Friday closed positive with 24 incliners, 11 decliners and 0 flat
· Thursday closed negative with 11 incliners, 24 decliners and 0 flat
· Wednesday closed negative with 13 incliners, 22 decliners and 0 flat
· Tuesday was a holiday
· Monday closed positive with 20 incliners, 13 decliners and 2 flats
Wednesday's inflation report could … upend recent gains; I’d am anxious to see if UPSIDE pricing will continue?
NOT feeling GOOD about the week – that means BAD. I am also maybe going … lighter this week (on writing) to TRY to get a vacation day or more just slow it down.
Earnings are about to be ready for release – questions are …RUNWAYS on track for further growth?
I hate to be so negative or contrarian but, this is a NO spin zone and truth is its product; I can always be WRONG but, I am mostly EARLY!
Opinions expressed are those of the author and are subject to change, and not intended to be a forecast of future events, a guarantee of future results, nor investment advice.
All investments are subject to risks. Investors should consider investment objectives.
Whether information or intelligence is good, bad or somewhere in between; I put into context what is relevant and useful for investors. All investments are subject to risks. Investors should consider investment objectives.
Regulation Analyst Certification (Reg AC): The research analyst primarily responsible for the content of this report certifies the following under Reg AC: I hereby certify that all views expressed in this report accurately reflect my personal views about the subject company or companies and its or their securities. I also certify that no part of my compensation was, is or will be, directly or indirectly, related to the specific recommendations or views expressed in this report.
Henry McCusker, the editor and publisher of RegMed Investors does not hold or have positions securities referred to in this publication.